LIVE SESSION BRIEF Equities Quant: STRONG BUY

Innovator IBD Breakout Opportunities ETF (BOUT) — Live Session & Technical Brief

Updated Nov 16, 2026 5:55 PM ET · Prev Close $39.24

Pro Workspace
Last Session Price
$38.85 -0.99%
-$0.39 vs $39.24 prior close
Intraday Range
$38.85 – $39.20
Open $39.20
Relative Volume
0.28x Avg
607 sh
52-Week Range
$35.05 – $49.41
Benchmark Alpha
+0.92% vs SPY
+1.68% vs QQQ
20-Session Trend -8.1%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-0.99%) in Equities

Innovator IBD Breakout Opportunities ETF (Bout) is trading within a tight intraday band at $38.85 (-0.99%, 0.28x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, BOUT is outperforming the S&P 500 by +0.92%. 14-day RSI stands at 35.1, keeping momentum in a bearish regime.

NEWS 70% Weight
Capital-Force Welcomes Ibd 50 Ffty and IBD Breakout Opportunities Bout ETFs to New Rules-Based ETF Platform

Los Angeles, April 29, 2026--M2 Financial LLC, in conjunction with Capital-Force ETF Trust Capital-FORCE , announced today the successful transition of the CapForce Ibd 50 ETF ticker FFTY and CapForce IBD Breakout Opport

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($38.85) trades relative to 20-day SMA ($40.46) and 50-day SMA ($41.94).

Volume Confirmation
LOW VOLUME (0.28x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

BOUT outperforming the S&P 500 by +0.92%
BOUT Session
-0.99%
$38.85
S&P 500 (SPY)
-1.91%
$739.95
Nasdaq 100 (QQQ)
-2.67%
$661.75
Alpha vs SPY: +0.92% Alpha vs QQQ: +1.68%

Recent BOUT Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$37.63
Short-term support band
Upper Bound
$40.07
Short-term resistance band
Key Inflection Level
$40.46 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $40.46 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (BOUT)

BEARISH MA TREND
RSI (14)
35.1
Bearish
20-Day SMA
$40.46
Below 20d
50-Day SMA
$41.94
Below 50d
MACD Signal
Bearish
MACD -0.90
ADX (14)
34.9
Strong trend
10d Momentum
-1.29
Soft 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Reddit communities: 1 comment (Neutral)

About Innovator IBD Breakout Opportunities ETF

Sector
Equities

Get Instant BOUT Catalyst Alerts

Receive an email alert when BOUT triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

BOUT Session & Catalyst FAQ

Why is BOUT stock trading near flat today?

Innovator IBD Breakout Opportunities ETF (Bout) is trading within a tight intraday band at $38.85 (-0.99%, 0.28x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, BOUT is outperforming the S&P 500 by +0.92%. 14-day RSI stands at 35.1, keeping momentum in a bearish regime.

Is BOUT stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.28x relative volume (low participation). Our multi-factor model currently rates BOUT as STRONG BUY. Review full valuation, quality, and timing signals on the BOUT Buy or Sell Decision Brief →

What is BOUT's intrinsic value and expected trading range?

At $38.85, BOUT's modeled 1-to-3 session range is $37.63 – $40.07, with a key inflection level at $40.46 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the BOUT Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for BOUT?

RSI at 35.1 reflects soft below-midline momentum. BOUT trades at $38.85 relative to its 20-day SMA ($40.46) and 50-day SMA ($41.94), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs